Zeolites ameliorate asbestos toxicity in a transgenic model of malignant mesothelioma
暂无分享,去创建一个
G. Reid | A. M. George | N. van Zandwijk | K. Schelch | C. Robinson | Xiyong Fan | Chris McLaughlin | Jason Ravasini | T. Johnson | A. George
[1] Nataša Pržulj,et al. Critical Review on Zeolite Clinoptilolite Safety and Medical Applications in vivo , 2018, Front. Pharmacol..
[2] David L. Gibbs,et al. Integrative Molecular Characterization of Malignant Pleural Mesothelioma. , 2018, Cancer discovery.
[3] A. M. George,et al. Zeolite protects mice from iron‐induced damage in a mouse model trial , 2018, FEBS open bio.
[4] Graham Dellaire,et al. Genomics and Epigenetics of Malignant Mesothelioma , 2018, High-throughput.
[5] Daniel M. Corey,et al. PD-1 expression by tumor-associated macrophages inhibits phagocytosis and tumor immunity , 2017, Nature.
[6] Y. Yoshioka,et al. Potential Suppressive Effects of Two C60 Fullerene Derivatives on Acquired Immunity , 2016, Nanoscale Research Letters.
[7] B. Thapa,et al. Immunotherapy for malignant mesothelioma: reality check , 2016, Expert review of anticancer therapy.
[8] Thomas D. Wu,et al. Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations , 2016, Nature Genetics.
[9] S. Catalani,et al. Reactive oxygen species a double-edged sword for mesothelioma , 2015, Oncotarget.
[10] G. Stella,et al. Malignant pleural mesothelioma: history, controversy and future of a manmade epidemic , 2015, European Respiratory Review.
[11] S. Mutsaers,et al. Long-term exposure of mesothelial cells to SV40 and asbestos leads to malignant transformation and chemotherapy resistance. , 2014, Carcinogenesis.
[12] C. Abendroth,et al. Anaplastic renal carcinoma expressing SV40 T antigen in a female TRAMP mouse. , 2013, Comparative medicine.
[13] C. Verschraegen,et al. New insights into understanding the mechanisms, pathogenesis, and management of malignant mesotheliomas. , 2013, The American journal of pathology.
[14] H. Matsuzaki,et al. Altered functions of alveolar macrophages and NK cells involved in asbestos-related diseases , 2013, Environmental Health and Preventive Medicine.
[15] E. Cassinerio,et al. An update on iron chelation therapy. , 2012, Blood transfusion = Trasfusione del sangue.
[16] P. Rascoe,et al. Molecular pathogenesis of malignant mesothelioma , 2012, Expert Reviews in Molecular Medicine.
[17] S. Toyokuni,et al. Asbestos surface provides a niche for oxidative modification , 2011, Cancer science.
[18] B. Cherayil. Iron and Immunity: Immunological Consequences of Iron Deficiency and Overload , 2010, Archivum Immunologiae et Therapiae Experimentalis.
[19] F. Carvalho,et al. Hepcidin messenger RNA expression in human lymphocytes , 2010, Immunology.
[20] S. Munkholm-Larsen,et al. Malignant peritoneal mesothelioma. , 2009, World journal of gastrointestinal surgery.
[21] J. Flowers,et al. clinical evidence supporting the use of an activated clinoptilolite suspension as an agent to increase urinary excretion of toxic heavy metals , 2009 .
[22] H. Byrne,et al. SWCNT suppress inflammatory mediator responses in human lung epithelium in vitro. , 2009, Toxicology and applied pharmacology.
[23] D. Kell. Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases , 2008, BMC Medical Genomics.
[24] Joan M Hevel,et al. Novel functional view of the crocidolite asbestos-treated A549 human lung epithelial transcriptome reveals an intricate network of pathways with opposing functions , 2008, BMC Genomics.
[25] V. Roggli,et al. Twenty-five years of fiber analysis: what have we learned? , 2008, Human pathology.
[26] J. Kanno,et al. Induction of mesothelioma in p53+/- mouse by intraperitoneal application of multi-wall carbon nanotube. , 2008, The Journal of toxicological sciences.
[27] Elisabetta Foresti,et al. Iron-loaded synthetic chrysotile: a new model solid for studying the role of iron in asbestos toxicity. , 2007, Chemical research in toxicology.
[28] B. Robinson,et al. A novel SV40 TAg transgenic model of asbestos-induced mesothelioma: malignant transformation is dose dependent. , 2006, Cancer research.
[29] M. Gulumian. An Update on the Detoxification Processes for Silica Particles and Asbestos Fibers: Successess and Limitations , 2005, Journal of toxicology and environmental health. Part B, Critical reviews.
[30] B. Robinson,et al. Advances in malignant mesothelioma. , 2005, The New England journal of medicine.
[31] A. Aust,et al. Role of iron in inactivation of epidermal growth factor receptor after asbestos treatment of human lung and pleural target cells. , 2005, American journal of respiratory cell and molecular biology.
[32] R. Gascoyne,et al. Immunohistochemical investigation of SV40 large T antigen in Hodgkin and non‐Hodgkin's lymphoma , 2004, International journal of cancer.
[33] S. Ivković,et al. Dietary supplementation with the tribomechanically activated zeolite clinoptilolite in immunodeficiency: Effects on the immune system , 2004, Advances in therapy.
[34] P. Dutta,et al. Analysis of the biological and chemical reactivity of zeolite-based aluminosilicate fibers and particulates. , 2002, Environmental health perspectives.
[35] R. Zadro,et al. The effect of the zeolite clinoptilolite on serum chemistry and hematopoiesis in mice. , 2001, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[36] S. Weitzman,et al. Asbestos causes apoptosis in alveolar epithelial cells: role of iron-induced free radicals. , 2001, The Journal of laboratory and clinical medicine.
[37] M. Katić,et al. Natural zeolite clinoptilolite: new adjuvant in anticancer therapy , 2001, Journal of Molecular Medicine.
[38] 베르두인요하네스피,et al. Crystalline molecular sieves , 1999 .
[39] I. Hassinen,et al. Generation of reactive oxygen species by human mesothelioma cells , 1999, British Journal of Cancer.
[40] C. Otero Areán,et al. Ferritin adsorption on amosite fibers: possible implications in the formation and toxicity of asbestos bodies. , 1997, Journal of toxicology and environmental health.
[41] J. Ernst,et al. Asbestos induces apoptosis of human and rabbit pleural mesothelial cells via reactive oxygen species. , 1996, The Journal of clinical investigation.
[42] J. Hardy,et al. The effect of iron binding on the ability of crocidolite asbestos to catalyze DNA single-strand breaks. , 1995, Carcinogenesis.
[43] J. Merchant. Human epidemiology: a review of fiber type and characteristics in the development of malignant and nonmalignant disease. , 1990, Environmental health perspectives.
[44] N. Kohyama,et al. Malignant mesothelioma induced by asbestos and zeolite in the mouse peritoneal cavity. , 1984, Environmental research.
[45] R. Doll. Mortality from Lung Cancer in Asbestos Workers , 1955 .
[46] F. Groenendaal,et al. Beneficial Effect of Erythropoietin on Sensorimotor Function and White Matter After Hypoxia-Ischemia in Neonatal Mice , 2011, Pediatric Research.
[47] A. Nowak,et al. MexTAg mice exposed to asbestos develop cancer that faithfully replicates key features of the pathogenesis of human mesothelioma. , 2011, European journal of cancer.
[48] M. Katić,et al. Immunostimulatory effect of natural clinoptilolite as a possible mechanism of its antimetastatic ability , 2001, Journal of Cancer Research and Clinical Oncology.
[49] E. Tátrai,et al. In vitro and in vivo tests for determination of the pathogenicity of quartz, diatomaceous earth, mordenite and clinoptilolite. , 2000, The Annals of occupational hygiene.
[50] J. Hardy,et al. Iron in Asbestos Chemistry and Carcinogenicity , 1995 .
[51] S. Weitzman,et al. The role of free radicals in asbestos-induced diseases. , 1992, Free radical biology & medicine.
[52] U. Brunk,et al. Effect of iron on the stability of macrophage lysosomes , 1983, Virchows Archiv. B, Cell pathology including molecular pathology.